PEOPLE (NTC03447678), a phase II trial to test pembrolizumab as first-line treatment in patients with advanced NSCLC with PD-L1 <50%: a multiomics analysis
Giuseppe Lo Russo, Arsela Prelaj, James Dolezal, Teresa Beninato, Luca Agnelli, Tiziana Triulzi, Alessandra Fabbri, Daniele Lorenzini, Roberto Ferrara, Marta Brambilla, Mario Occhipinti, Laura Mazzeo, Leonardo Provenzano, Andrea Spagnoletti, Giuseppe Viscardi, Francesco Sgambelluri, Silvia Brich, Vanja Miskovic, Alessandra Laura Giulia Pedrocchi, Francesco Trovo', Sara Manglaviti, Claudia Giani, Paolo Ambrosini, Rita Leporati, Andrea Franza, John McCulloch, Tommaso Torelli, Andrea Anichini, Roberta Mortarini, Giorgio Trinchieri, Giancarlo Pruneri, Valter Torri, Filippo De Braud, Claudia Proto, Monica Ganzinelli, Marina Chiara Garassino
Journal for ImmunoTherapy of Cancer Jun 2023, 11 (6) e006833; DOI: 10.1136/jitc-2023-006833